Search Within

Wassim Abida

Formats
  1. Meeting Abstract (75)
  2. Journal Article (72)
  3. Review (5)
  4. Editorial (4)
  5. Research Letter (2)
  6. Correspondence (1)
  7. Guidelines (1)
Groups
  1. Department of Medicine (160)
  2. Genitourinary Oncology Service (160)
  3. Solid Tumor Oncology Division (160)
  4. GSK Faculty (72)
  5. Human Oncology and Pathogenesis Program (68)
  6. Sloan Kettering Institute Postdocs (60)

More Groups

People
  1. Howard Scher (68)
  2. Michael Morris (39)
  3. David Solit (36)
  4. Nikolaus Schultz (33)
  5. Anuradha Gopalan (31)
  6. Dana Rathkopf (31)

More People

Years
  1. 2025 (10)
  2. 2024 (10)
  3. 2023 (14)
  4. 2022 (15)
  5. 2021 (19)
  6. 2020 (27)

More Years

Publications
  1. Journal of Clinical Oncology (40)
  2. Clinical Cancer Research (15)
  3. Annals of Oncology (13)
  4. Cancer Research (13)
  5. European Urology (8)
  6. JCO Precision Oncology (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (44)
  2. American Association for Cancer Research (31)
  3. Nature Publishing Group (17)
  4. Oxford University Press (13)
  5. Elsevier Science, Inc. (10)
  6. Nature Research (5)

More Publishers

Results (160)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Interim results of AASUR: A single arm, multi-center phase 2 trial of apalutamide (A) + abiraterone acetate + prednisone (AA plus P) + leuprolide with stereotactic ultra-hypofractionated radiation (UHRT) in very high risk (VHR), node negative (N0) prostate cancer (PCa)
    Meeting Abstract

    McBride, S. M.; Spratt, D. E.; Kollmeier, M.; Abida, W.; Xiao, H.; Slovin, S. F.; Paller, C. J.; Deville, C.; Den, R. B.; Hearn, J. W. D.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Characterization of findings on prostate cancer tumor sequencing that should prompt consideration for germline testing
    Meeting Abstract

    Truong, H.; Breen, K.; Kemel, Y.; Lenis, A. T.; Reisz, P.; Benfante, N.; Ehdaie, B.; Touijer, K. A.; Laudone, V. P.; Scardino, P. T.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Tazemetostat in combination with a PARP Inhibitor or checkpoint inhibitor in patients (Pts) with solid tumors
    Meeting Abstract

    Rudin, C. M.; Abida, W.; Spira, A.; Chadha, R.; Yang, J.; Powers, D.; Coleman, R.
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Safety of tazemetostat (TAZ) in combination with abiraterone/prednisone (A/P) or enzalutamide (E) in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Abida, W.; Iannotti, N.; Kocabas Argon, E.; Appleman, L.; Michaud, N.; Rajarethinam, A.; Adib, D.; Saltzstein, D. R.
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • A phase Ib study of enzalutamide (Enza) plus CC-115 in men with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Zhao, J. L.; Antonarakis, S.; Cheng, H.; George, D. J.; Aggarwal, R. R.; Abida, W.; Decker, B.; Smart-Curley, T.; Schonhoft, J.; Anderson, A.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Therapeutic implications of germline testing in patients with advanced cancers
    Journal Article

    Stadler, Z. K.; Maio, A.; Chakravarty, D.; Kemel, Y.; Sheehan, M.; Salo-Mullen, E.; Tkachuk, K.; Fong, C. J.; Nguyen, B.; Erakky, A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • BET bromodomain inhibition blocks an AR-repressed, E2F1-activated treatment-emergent neuroendocrine prostate cancer lineage plasticity program
    Journal Article

    Kim, D. H.; Sun, D.; Storck, W. K.; Leng, K. W.; Jenkins, C.; Coleman, D. J.; Sampson, D.; Guan, X.; Kumaraswamy, A.; Rodansky, E. S.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Genomic analysis of circulating tumor DNA in 3,334 patients with advanced prostate cancer identifies targetable BRCA alterations and AR resistance mechanisms
    Journal Article

    Tukachinsky, H.; Madison, R. W.; Chung, J. H.; Gjoerup, O. V.; Severson, E. A.; Dennis, L.; Fendler, B. J.; Morley, S.; Zhong, L.; Graf, R. P.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS
    Journal Article

    Brannon, A. R.; Jayakumaran, G.; Diosdado, M.; Patel, J.; Razumova, A.; Hu, Y.; Meng, F.; Haque, M.; Sadowska, J.; Murphy, B. J.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients
    Journal Article

    Tsui, D. W. Y.; Cheng, M. L.; Shady, M.; Yang, J. L.; Stephens, D.; Won, H.; Srinivasan, P.; Huberman, K.; Meng, F.; Jing, X.; more...
    Genome Medicine (2021)

    Fulltext@MSK | Save